
AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of immune cells
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of…
In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body’s immune system…
Early and repeated exposures to diagnostic imaging, such as X-rays and CT scans, may increase…
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for…
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better…
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…
PPIs are commonly used medications for acid reflux, heartburn, and ulcers. Recent evidence indicates that…